The role of decellularization in biometarials manufacturing from xenogeneic tissues
暂无分享,去创建一个
[1] J. Fisher,et al. In-vitro assessment of the functional performance of the decellularized intact porcine aortic root. , 2005, The Journal of heart valve disease.
[2] A Haverich,et al. Acellularized porcine heart valve scaffolds for heart valve tissue engineering and the risk of cross-species transmission of porcine endogenous retrovirus. , 2003, The Journal of thoracic and cardiovascular surgery.
[3] John Fisher,et al. Tissue engineering of cardiac valve prostheses I: development and histological characterization of an acellular porcine scaffold. , 2002, The Journal of heart valve disease.
[4] A. C. Yankah,et al. Surgical management of acute aortic root endocarditis with viable homograft: 13-year experience. , 2002, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[5] B. Oesch,et al. Analysis of the risk of transmitting bovine spongiform encephalopathy through bone grafts derived from bovine bone. , 2001, Biomaterials.
[6] A Haverich,et al. Heart valves from pigs and the porcine endogenous retrovirus: experimental and clinical data to assess the probability of porcine endogenous retrovirus infection in human subjects. , 2001, The Journal of thoracic and cardiovascular surgery.
[7] C. Schmidt,et al. Acellular vascular tissues: natural biomaterials for tissue repair and tissue engineering. , 2000, Biomaterials.
[8] A Haverich,et al. Tissue Engineering of Pulmonary Heart Valves on Allogenic Acellular Matrix Conduits: In Vivo Restoration of Valve Tissue , 2000, Circulation.
[9] A Haverich,et al. Tissue engineering of heart valves--human endothelial cell seeding of detergent acellularized porcine valves. , 1998, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[10] D. Doty,et al. Aortic valve replacement with cryopreserved aortic allograft: ten-year experience. , 1998, The Journal of thoracic and cardiovascular surgery.
[11] E. Khor. Methods for the treatment of collagenous tissues for bioprostheses. , 1997, Biomaterials.
[12] T. Sundt,et al. Fourteen-year experience with homovital homografts for aortic valve replacement. , 1995, The Journal of thoracic and cardiovascular surgery.
[13] Phillips Re,et al. The role of material surface chemistry in implant device calcification: a hypothesis. , 1995 .
[14] M E Nimni,et al. Toxic reactions evoked by glutaraldehyde-fixed pericardium and cardiac valve tissue bioprosthesis. , 1984, Journal of biomedical materials research.